2002, Number 3
PDF size: 100.39 Kb.
ABSTRACTThe oral drug treatment for the erectile sexual dysfunction is revised, explaining the need of achieving more effective drugs, making an historical account of such treatment modality and making clear the actual problems that exist in the evaluation of drugs for the oral treatment of erectile sexual dysfunction. The actual strategies for the treatment of the affection mentioned are updated, and finally, a peer-reviewed exposition is made of the clinical essays performed up to now, of the erectogenic drugs classified by pharmacological groups (dopaminergic agonists, b adrenergic antagonists, b adrenergic agonists, serotoninergics, colinergics, phosphodiesterease inhibitors, nitrous oxide precursors, prostanoids an hormones).
Saenz de Tejada I, Cuevas P, Cuevas B, Fernández A, Schroeder J, Shelekin T, Letts G, Garvey D. S-Nitrosylated alpha blockers as potential drugs for the treatment of impotence: Biological activity of NMI-187 and NMI-221. Int J of Imp Res 8. (3).: VII World Meeting on Impotence. (Abstracts). 1996; 103: A-16.
Gingell C, Jardin A, Giuliano FA, Olsson AM, Dinsmore WW, Osterloh IH. The efficacy of Sildenafil (Viagra), a new oral treatment for erectile dysfunction, demonstrated by four different methods in a double-blind placebo-controlled, multinational clinical trial. (Abstract). Eur Urol 1996; 30 (Suppl 2): 353.
Derry F, Glass C, Dinsmore WW, Fraser M, Gardner BP, Mayton M. Sildenafil (Viagra): an oral treatment for men with erectile dysfunction caused by traumatic spinal cord injury- a 28 day, double-blind, placebo-controlled, parallel-group dose-response study. (Abstract). Neurology 1997; 48 (Suppl 2): 215.
Gardner BP, Mandeville S, Glass C, Fraser M, Dinsmore WW, Muirhead G, Maytom MC, Orr M. Sildenafil (ViagraTM): A double blind, placebo-controlled, single dose, two-way crossover study in men with erectile dysfunction caused by traumatic spinal cord injury. J Urol 1997; 157. (4). (Suppl): 181 (Abstract) 702.